News | October 06, 2023
Ministry of Ayush to launch special campaign 3.0,
The Main campaign started from October 2
The Main campaign started from October 2
His M&A background and experience with successful private-equity-backed companies will benefit the company’s growth and diversification strategy
This product is bioequivalent to the reference listed drug (RLD), Nexium 24 HR Delayed- Release Capsules, 2.0mg (OTC), of AstraZeneca Pharmaceuticals
The company has received six final approvals that includes Chlorpromazine Hydrochloride Tablets
The product is bioequivalent and therapeutically equivalent to the RLD, Vascepa of Amarin
Palivizumab (Synagis) is indicated for the prevention of serious lower respiratory tract disease requiring hospitalization caused by respiratory syncytial virus
The sale/transfer of the Company's API NonAntibiotic Business and API Antibiotic Business to Apitoria are complete
Aim is to treat Dyslipidemia by inhibiting PCSK9 with a novel entity
The discoveries by the two Nobel Laureates were critical for developing effective mRNA vaccines against COVID-19
Balaxi Healthcare Ecuador S.A.S. has become a Wholly Owned Subsidiary of the company
Subscribe To Our Newsletter & Stay Updated
